Controlled Release in Oral Drug Delivery

Wilson, Clive G. (EDT)/ Crowley, Patrick J. (EDT)

Editore: Springer Verlag, 2011
ISBN 10: 1461410037 / ISBN 13: 9781461410034
Usato / Hardcover / Quantità: 0
Copie del libro da altre librerie
Mostra tutte le  copie di questo libro

Libro

Purtroppo questa copia non è più disponibile. Di seguito ti proponiamo una lista di copie simili.

Descrizione:

Our orders are sent from our warehouse locally or directly from our international distributors to allow us to offer you the best possible price and delivery time. Codice inventario libreria

Su questo libro:

Book ratings provided by Goodreads):
5 valutazione media
(2 valutazioni)

Riassunto: Controlled Release in Oral Drug Delivery provides focus on specific topics, complementing other books in the initial CRS series. Each chapter sets the context for the inventions described and describe the latitude that the inventions allow. In order to provide some similar look to each chapter, the coverage includes the historical overview, candidate drugs, factors influencing design and development, formulation and manufacturing and delivery system design. This volume was written along three main sections: the relevant anatomy and physiology, a discussion on candidates for oral drug delivery and the major three groups of controlled release systems: diffusion control (swelling and inert matrices); environmental control (pH sensitive coatings, time control, enzymatic control, pressure control) and finally lipidic systems.

From the Back Cover:

Controlling the rate, extent and time of a drug’s delivery can optimize its performance in many ways, relative to “immediate release” delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to “reduce to practice” also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem.

 

Traditionally, controlled release systems tended to be “second-generation products, building on accumulated clinical experience.  However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development.

 

Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences.  It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions.

 

Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary.

Major areas of research have been the study of the behaviour of drug formulations in man.  With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man.  This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and  studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010.

 

Patrick Crowley has over 40 years’ experience in dosage form development in the pharmaceutical industry, in both the UK and USA.  He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Dati bibliografici

Titolo: Controlled Release in Oral Drug Delivery
Casa editrice: Springer Verlag
Data di pubblicazione: 2011
Legatura: Hardcover
Condizione libro: New
Edizione: 1.

I migliori risultati di ricerca su AbeBooks

1.

Wilson, Clive G.
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Quantità: 1
Da
Paperbackshop-US
(Wood Dale, IL, U.S.A.)
Valutazione libreria
[?]

Descrizione libro 2011. HRD. Condizione libro: New. New Book. Shipped from US within 10 to 14 business days. Established seller since 2000. Codice libro della libreria KS-9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 205,70
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 3,38
In U.S.A.
Destinazione, tempi e costi

2.

Editore: Springer-Verlag New York Inc., United States (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Rilegato Quantità: 1
Da
The Book Depository US
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., United States, 2011. Hardback. Condizione libro: New. 2011. Language: English . Brand New Book. Controlled Release in Oral Drug Delivery provides focus on specific topics, complementing other books in the initial CRS series. Each chapter sets the context for the inventions described and describe the latitude that the inventions allow. In order to provide some similar look to each chapter, the coverage includes the historical overview, candidate drugs, factors influencing design and development, formulation and manufacturing and delivery system design. This volume was written along three main sections: the relevant anatomy and physiology, a discussion on candidates for oral drug delivery and the major three groups of controlled release systems: diffusion control (swelling and inert matrices); environmental control (pH sensitive coatings, time control, enzymatic control, pressure control) and finally lipidic systems. Codice libro della libreria LIB9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 209,17
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

3.

Editore: Springer-Verlag New York Inc., United States (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Rilegato Quantità: 1
Da
The Book Depository
(London, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., United States, 2011. Hardback. Condizione libro: New. 2011. Language: English . Brand New Book. Controlled Release in Oral Drug Delivery provides focus on specific topics, complementing other books in the initial CRS series. Each chapter sets the context for the inventions described and describe the latitude that the inventions allow. In order to provide some similar look to each chapter, the coverage includes the historical overview, candidate drugs, factors influencing design and development, formulation and manufacturing and delivery system design. This volume was written along three main sections: the relevant anatomy and physiology, a discussion on candidates for oral drug delivery and the major three groups of controlled release systems: diffusion control (swelling and inert matrices); environmental control (pH sensitive coatings, time control, enzymatic control, pressure control) and finally lipidic systems. Codice libro della libreria LIB9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 212,19
Convertire valuta

Aggiungere al carrello

Spese di spedizione: GRATIS
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

4.

Wilson, Clive G.
Editore: Springer (2016)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Paperback Quantità: 1
Print on Demand
Da
Ria Christie Collections
(Uxbridge, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2016. Paperback. Condizione libro: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Codice libro della libreria ria9781461410034_lsuk

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 212,20
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 4,33
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

5.

Clive G. Wilson
Editore: Springer-Verlag Gmbh Sep 2011 (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Quantità: 2
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Sep 2011, 2011. Buch. Condizione libro: Neu. Neuware - Controlling the rate, extent and time of a drug s delivery can optimize its performance in many ways, relative to immediate release delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to reduce to practice also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem. Traditionally, controlled release systems tended to be second-generation products, building on accumulated clinical experience. However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development. Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences. It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions. Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary. Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010. Patrick Crowley has over 40 years experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control. 412 pp. Englisch. Codice libro della libreria 9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 219,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 12,00
Da: Germania a: U.S.A.
Destinazione, tempi e costi

6.

Clive G. Wilson
Editore: Springer-Verlag Gmbh Sep 2011 (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Quantità: 2
Da
Rheinberg-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Sep 2011, 2011. Buch. Condizione libro: Neu. Neuware - Controlling the rate, extent and time of a drug s delivery can optimize its performance in many ways, relative to immediate release delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to reduce to practice also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem. Traditionally, controlled release systems tended to be second-generation products, building on accumulated clinical experience. However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development. Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences. It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions. Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary. Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010. Patrick Crowley has over 40 years experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control. 412 pp. Englisch. Codice libro della libreria 9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 219,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,13
Da: Germania a: U.S.A.
Destinazione, tempi e costi

7.

Clive G. Wilson
Editore: Springer-Verlag Gmbh Sep 2011 (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Quantità: 2
Da
Agrios-Buch
(Bergisch Gladbach, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Sep 2011, 2011. Buch. Condizione libro: Neu. Neuware - Controlling the rate, extent and time of a drug s delivery can optimize its performance in many ways, relative to immediate release delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to reduce to practice also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem. Traditionally, controlled release systems tended to be second-generation products, building on accumulated clinical experience. However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development. Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences. It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions. Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary. Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010. Patrick Crowley has over 40 years experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control. 412 pp. Englisch. Codice libro della libreria 9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 219,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 17,13
Da: Germania a: U.S.A.
Destinazione, tempi e costi

8.

Clive G. Wilson
Editore: Springer-Verlag Gmbh Sep 2011 (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Quantità: 2
Da
AHA-BUCH GmbH
(Einbeck, Germania)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag Gmbh Sep 2011, 2011. Buch. Condizione libro: Neu. Neuware - Controlling the rate, extent and time of a drug s delivery can optimize its performance in many ways, relative to immediate release delivery. Such optimized design requires a broad knowledge base of topics such as gastro intestinal tract physiology, polymer science, and the mechanisms by which drugs are released from the formulated units. Technologies to reduce to practice also need to be carefully considered. Such knowledge must be allied to the physico chemical properties of the drug, its pharmacokinetic behaviors, enzyme susceptibility and other factors that can affect absorption or timecourse in the biosystem. Traditionally, controlled release systems tended to be second-generation products, building on accumulated clinical experience. However, better awareness of the molecular biology of drug action and the promise of biomarkers and personalized medicine may mean that optimizing performance by controlling release may become a first option in new product development. Such optimization may well help reduce the alarming attrition rates that are now prevalent in new drug development. Controlled Release in Oral Drug Delivery provides chapters, dealing with all facets of the above subject matter, and its challenges. Authors have been drawn from academia, providers of excipients and from those designing controlled release systems in industrial R&D and manufacture. The contents provide a unique blend of cutting edge knowledge, data on materials and practical experiences. It is essential text for students, researchers and industrial engineering, formulation and manufacturing technologists as well as quality testing and control functions. Clive Wilson is the J. P. Todd Professor of Pharmaceutics at Strathclyde University in Glasgow, Scotland and the current president of the European Union Federation for Pharmaceutical Sciences. He is the Chief Scientist of Bio-Images Research Group, a Phase II imaging specialist clinical unit in Glasgow Royal Infirmary. Major areas of research have been the study of the behaviour of drug formulations in man. With colleagues at Nottingham, he pioneered applications of scintigraphy in the study of physiological and patho-physiological effects of transit on drug absorption and began the investigations into regional drug absorption in man. This was later applied to the design and optimisation of oral dosage forms, in silico modelling of formulations in man and studies on IVIVR. He has published more than 150 papers, six books and over 130 reviews and book chapters. He was made a fellow of the Controlled Release Society in June 2010 and a Fellow of the Academy of Pharmaceutical Sciences in September 2010. Patrick Crowley has over 40 years experience in dosage form development in the pharmaceutical industry, in both the UK and USA. He has played key roles in the development of 16 commercial products, including fermentation products, semi synthetics, synthetic structures and a biopharmaceutical product and holds several formulation-related Patents. His interests and publications include drug and product stability, enhancing performance by dosage form design and the application of Quality by Design principles and practices in dosage form development, manufacture and control. 412 pp. Englisch. Codice libro della libreria 9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 219,99
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 29,50
Da: Germania a: U.S.A.
Destinazione, tempi e costi

9.

Clive G. Wilson
Editore: Springer-Verlag New York Inc. (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Quantità: > 20
Print on Demand
Da
Books2Anywhere
(Fairford, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer-Verlag New York Inc., 2011. HRD. Condizione libro: New. New Book. Delivered from our US warehouse in 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND.Established seller since 2000. Codice libro della libreria IP-9781461410034

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 217,80
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 10,08
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

10.

CLIVE G. WILSON
Editore: Springer (2011)
ISBN 10: 1461410037 ISBN 13: 9781461410034
Nuovi Rilegato Quantità: 1
Da
Herb Tandree Philosophy Books
(Stroud, GLOS, Regno Unito)
Valutazione libreria
[?]

Descrizione libro Springer, 2011. Hardback. Condizione libro: NEW. 9781461410034 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Codice libro della libreria HTANDREE0303739

Maggiori informazioni su questa libreria | Fare una domanda alla libreria

Compra nuovo
EUR 225,90
Convertire valuta

Aggiungere al carrello

Spese di spedizione: EUR 8,96
Da: Regno Unito a: U.S.A.
Destinazione, tempi e costi

Vedi altre 14 copie di questo libro

Vedi tutti i risultati per questo libro